SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway.

ABSTRACT: Structure-specific recognition protein 1 (SSRP1) has been considered as a potential biomarker, since aberrant high expression of SSRP1 has been detected in numerous malignant tumors. However, the correlation between the expression level of SSRP1 and glioma remains unclear. The present study attempted to investigate the role of SSRP1 in the pathogenesis of glioma. In the present study, our data revealed that SSRP1 overexpression was detected in glioma tissues at both the mRNA and protein levels using quantitative real-time RT-PCR and immunohistochemical analysis. We also demonstrated that the upregulated expression of SSRP1 was correlated with the World Health Organization (WHO) grade of glioma. The knockdown of SSRP1 by siRNA not only resulted in the inhibition of cell proliferation, but a

SUBMITTER: Liao J 

PROVIDER: S-EPMC5780019 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature